Vimarsana
Biggest News Aggregation in the World

Page 28 - Life Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Technologies Today - Breaking & Trending Today

Stakeholder Divisions Hang Over Section 101 Reform Efforts As Supreme Court Winnows Alice Appeals - Intellectual Property - Vimarsana News

Stakeholder Divisions Hang Over Section 101 Reform Efforts As Supreme Court Winnows Alice Appeals - Intellectual Property

The Supreme Court's Alice decision once provided a key offramp for defendants hoping to challenge patent eligibility, but subsequent decisions have narrowed their ability to succeed...

Source: mondaq.com
NanoString Announces Commercial Leadership Transition - Vimarsana News

NanoString Announces Commercial Leadership Transition

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
NanoString Announces Commercial Leadership Transition - Vimarsana News

NanoString Announces Commercial Leadership Transition

09.01.2022 - NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a commercial leadership transition. Chad Brown, who has served as senior vice president of Sales & ... Seite 1

Frontiers | Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1 - Vimarsana News

Frontiers | Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1

Chronic lymphocytic leukemia (CLL) has experienced a clinical revolution thanks to the discovery of crucial pathogenetic mechanisms. CLL is still an incurable disease due to intrinsic or acquired resistance of the leukemic clone. Venetoclax is a Bcl-2 inhibitor with a marked activity in CLL, but emerging patterns of resistance are being described. We hypothesize that intrinsic features of CLL cells may contribute to drive mechanisms of resistance to venetoclax. We analyzed the expression of IRF4, Notch2 and Mcl-1 in a cohort of CLL patients. We evaluated CLL cells viability after genetic and p...

MicroRNA (miRNA) Market 2022 Global Estimation, Dynamics, Outlook, Research, Trends and Forecasts To 2028 - Vimarsana News

MicroRNA (miRNA) Market 2022 Global Estimation, Dynamics, Outlook, Research, Trends and Forecasts To 2028

MicroRNA (miRNA) Market 2022 Global Estimation, Dynamics, Outlook, Research, Trends and Forecasts To 2028